Literature DB >> 10537173

Prolactin is a survival factor for androgen-deprived rat dorsal and lateral prostate epithelium in organ culture.

T J Ahonen1, P L Härkönen, J Laine, H Rui, P M Martikainen, M T Nevalainen.   

Abstract

PRL is one of several polypeptide factors that regulate growth and differentiation of prostate epithelium besides steroid hormones. This hormone may also participate in the development of pathologic changes of the prostate, as evidenced by marked prostate hyperplasia in hyperprolactinemic mice. We have previously demonstrated expression of PRL receptors and androgen-dependent local production of PRL in rat and human prostate epithelium, suggesting the existence of an autocrine loop. We now show that PRL acts as a survival factor for epithelial cells of rat dorsal and lateral prostate but not ventral prostate, using long-term organ cultures as an in vitro model. Culture of prostate explants in androgen-free medium was associated with a transient surge of apoptosis during the first 2-4 days of culture in rat ventral, dorsal, and lateral prostate tissues, as quantified by either nuclear morphology or in situ DNA fragmentation analysis. PRL significantly inhibited apoptosis in androgen-deprived dorsal and lateral prostate cultures, by 40-60%, as determined by the two methods. The present study has established conditions and methodology for analysis of apoptosis in organ cultures of rat prostate and suggests a physiological role for PRL as a survival factor for prostate epithelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10537173     DOI: 10.1210/endo.140.11.7090

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  24 in total

Review 1.  Minireview: prolactin regulation of adult stem cells.

Authors:  Lucila Sackmann-Sala; Jacques-Emmanuel Guidotti; Vincent Goffin
Journal:  Mol Endocrinol       Date:  2015-03-20

2.  A Novel Nectin-mediated Cell Adhesion Apparatus That Is Implicated in Prolactin Receptor Signaling for Mammary Gland Development.

Authors:  Midori Kitayama; Kiyohito Mizutani; Masahiro Maruoka; Kenji Mandai; Shotaro Sakakibara; Yuki Ueda; Takahide Komori; Yohei Shimono; Yoshimi Takai
Journal:  J Biol Chem       Date:  2016-01-12       Impact factor: 5.157

3.  Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.

Authors:  Tuomas Mirtti; Benjamin E Leiby; Junaid Abdulghani; Elina Aaltonen; Miia Pavela; Anita Mamtani; Kalle Alanen; Lars Egevad; Torvald Granfors; Andreas Josefsson; Par Stattin; Anders Bergh; Marja T Nevalainen
Journal:  Hum Pathol       Date:  2012-09-29       Impact factor: 3.466

4.  Estrogen action and prostate cancer.

Authors:  Jason L Nelles; Wen-Yang Hu; Gail S Prins
Journal:  Expert Rev Endocrinol Metab       Date:  2011-05

5.  Prolactin stimulates prostate cell proliferation by increasing endoplasmic reticulum content due to SERCA 2b over-expression.

Authors:  Alexandre Crépin; Gabriel Bidaux; Fabien Vanden-Abeele; Etienne Dewailly; Vincent Goffin; Natalia Prevarskaya; Christian Slomianny
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

6.  Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo.

Authors:  Lei Gu; Paraskevi Vogiatzi; Martin Puhr; Ayush Dagvadorj; Jacqueline Lutz; Amy Ryder; Sankar Addya; Paolo Fortina; Carlton Cooper; Benjamin Leiby; Abhijit Dasgupta; Terry Hyslop; Lukas Bubendorf; Kalle Alanen; Tuomas Mirtti; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2010-05-18       Impact factor: 5.678

7.  Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.

Authors:  Zhiyong Liao; Lei Gu; Jenny Vergalli; Samanta A Mariani; Marco De Dominici; Ravi K Lokareddy; Ayush Dagvadorj; Puranik Purushottamachar; Peter A McCue; Edouard Trabulsi; Costas D Lallas; Shilpa Gupta; Elyse Ellsworth; Shauna Blackmon; Adam Ertel; Paolo Fortina; Benjamin Leiby; Guanjun Xia; Hallgeir Rui; David T Hoang; Leonard G Gomella; Gino Cingolani; Vincent Njar; Nagarajan Pattabiraman; Bruno Calabretta; Marja T Nevalainen
Journal:  Mol Cancer Ther       Date:  2015-05-29       Impact factor: 6.261

8.  Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation.

Authors:  Fabien Van Coppenolle; Roman Skryma; Halima Ouadid-Ahidouch; Christian Slomianny; Morad Roudbaraki; Philippe Delcourt; Etienne Dewailly; Sandrine Humez; Alexandre Crépin; Isabelle Gourdou; Jean Djiane; Jean-Louis Bonnal; Brigitte Mauroy; Natalia Prevarskaya
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

9.  Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.

Authors:  Pooja G Talati; Lei Gu; Elyse M Ellsworth; Melanie A Girondo; Marco Trerotola; David T Hoang; Benjamin Leiby; Ayush Dagvadorj; Peter A McCue; Costas D Lallas; Edouard J Trabulsi; Leonard Gomella; Andrew E Aplin; Lucia Languino; Alessandro Fatatis; Hallgeir Rui; Marja T Nevalainen
Journal:  Am J Pathol       Date:  2015-09       Impact factor: 4.307

10.  Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity.

Authors:  Kuang-tzu Huang; Ameae M Walker
Journal:  Prostate       Date:  2010-01-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.